Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
696 | 3088 | 51.1 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | STUDY HEPATITIS C | Address | 60 | 41% | 4% | 115 |
2 | U748 | Address | 47 | 61% | 2% | 50 |
3 | VIROL INFECT DIS | Address | 46 | 43% | 3% | 83 |
4 | UPR2511 | Address | 45 | 94% | 1% | 16 |
5 | VIROL 2 | Address | 42 | 24% | 5% | 151 |
6 | COPENHAGEN HEPATITIS PROGRAM CO HEP C | Address | 36 | 71% | 1% | 29 |
7 | CORE PROTEIN | Author keyword | 33 | 34% | 3% | 80 |
8 | NS5A | Author keyword | 28 | 38% | 2% | 58 |
9 | NS4B | Author keyword | 23 | 65% | 1% | 22 |
10 | U1110 | Address | 23 | 60% | 1% | 25 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CORE PROTEIN | 33 | 34% | 3% | 80 | Search CORE+PROTEIN | Search CORE+PROTEIN |
2 | NS5A | 28 | 38% | 2% | 58 | Search NS5A | Search NS5A |
3 | NS4B | 23 | 65% | 1% | 22 | Search NS4B | Search NS4B |
4 | MEMBRANOUS WEB | 21 | 85% | 0% | 11 | Search MEMBRANOUS+WEB | Search MEMBRANOUS+WEB |
5 | HCV ENTRY | 15 | 82% | 0% | 9 | Search HCV+ENTRY | Search HCV+ENTRY |
6 | CD81 | 14 | 30% | 1% | 38 | Search CD81 | Search CD81 |
7 | P7 | 14 | 57% | 1% | 16 | Search P7 | Search P7 |
8 | REPLICON | 11 | 20% | 2% | 47 | Search REPLICON | Search REPLICON |
9 | HCV REPLICATION | 9 | 44% | 1% | 16 | Search HCV+REPLICATION | Search HCV+REPLICATION |
10 | HCV STRUCTURAL PROTEINS | 9 | 83% | 0% | 5 | Search HCV+STRUCTURAL+PROTEINS | Search HCV+STRUCTURAL+PROTEINS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CD81 BINDING | 211 | 96% | 2% | 67 |
2 | RNA REPLICATION | 193 | 37% | 14% | 421 |
3 | NONSTRUCTURAL PROTEIN 5A | 173 | 70% | 5% | 146 |
4 | CD81 | 111 | 50% | 5% | 159 |
5 | EFFICIENT REPLICATION | 105 | 58% | 4% | 121 |
6 | CELL CULTURE SYSTEMS | 90 | 82% | 2% | 53 |
7 | ENTRY FACTOR | 89 | 100% | 1% | 27 |
8 | B TYPE I | 86 | 38% | 6% | 183 |
9 | SUBGENOMIC REPLICON | 85 | 69% | 2% | 72 |
10 | CORE PROTEIN | 69 | 15% | 13% | 412 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Hepatitis C virus NS5A: enigmatic but still promiscuous 10 years on! | 2015 | 7 | 79 | 91% |
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies | 2013 | 105 | 159 | 70% |
Assembly of infectious hepatitis C virus particles | 2011 | 142 | 92 | 84% |
Replication of hepatitis C virus | 2007 | 611 | 119 | 55% |
Hepatitis C Virus Entry | 2013 | 44 | 165 | 84% |
The ins and outs of hepatitis C virus entry and assembly | 2013 | 46 | 150 | 81% |
Hepatitis C Virus Proteins: From Structure to Function | 2013 | 50 | 123 | 74% |
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection | 2013 | 66 | 150 | 56% |
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies | 2011 | 75 | 145 | 80% |
Unravelling hepatitis C virus replication from genome to function | 2005 | 427 | 96 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STUDY HEPATITIS C | 60 | 41% | 3.7% | 115 |
2 | U748 | 47 | 61% | 1.6% | 50 |
3 | VIROL INFECT DIS | 46 | 43% | 2.7% | 83 |
4 | UPR2511 | 45 | 94% | 0.5% | 16 |
5 | VIROL 2 | 42 | 24% | 4.9% | 151 |
6 | COPENHAGEN HEPATITIS PROGRAM CO HEP C | 36 | 71% | 0.9% | 29 |
7 | U1110 | 23 | 60% | 0.8% | 25 |
8 | HEPATITIS VIRUS C | 17 | 75% | 0.4% | 12 |
9 | EQUIPE HEPATITE C | 15 | 82% | 0.3% | 9 |
10 | HEPATITIS C GRP | 15 | 88% | 0.2% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196739 | NS5B POLYMERASE//HCV NS5B POLYMERASE//NS3 PROTEASE |
2 | 0.0000148355 | OCCULT HCV//OCCULT HEPATITIS C//OCCULT HCV INFECTION |
3 | 0.0000140766 | HCV GENOTYPES//INTERFERON SENSITIVITY DETERMINING REGION//HYPERVARIABLE REGION 1 |
4 | 0.0000136250 | INTEGRATED PROGRAM IMMUNOL//DENDRIT CELL BIOL CLIN PLICAT//LIVER DIS SECT |
5 | 0.0000131991 | STEATOSIS//HEPATOGENOUS DIABETES//DIPARTIMENTO MED GASTROENTEROL ALMA MATER STUDI |
6 | 0.0000076851 | TELAPREVIR//RIBAVIRIN//BOCEPREVIR |
7 | 0.0000068418 | IRES//INTERNAL RIBOSOME ENTRY SITE IRES//INTERNAL RIBOSOME ENTRY SITE |
8 | 0.0000060360 | AUREOBASIDIUM SPP//BREAKTHROUGH FUNGAEMIA//METALS METALLOIDS |
9 | 0.0000056983 | RIBA//ANTI HCV//NON A NON B HEPATITIS |
10 | 0.0000047883 | M65//M30//M65 ELISA |